Jci_page_head_homepage_01 Jci_page_head_homepage_02
Raheem Peerani, Peter W. Zandstra
Published in Volume 120, Issue 1
J Clin Invest. 2010; 120(1):60–70 doi:10.1172/JCI41158
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4
Engineering and modulating the niche in vivo.

This figure provides an overview of different clinically relevant strategies that may be used to manipulate the in vivo stem cell niche. Examples provided illustrate the molecular targeting of particular stem cell–niche interactions. CML, chronic myeloid leukemia; LSC, leukemic stem cell.